News

Spike Protein

Anti-S1 Domain Spike Protein is now available at Diaclone

Publication date : 2020-08-03

Ideal for your COVID-19 studies...

The antibody Anti-SARS-CoV-2 Spike S1 Protein CR3022 recognizes the S1 domain of the SARS-CoV Spike protein (aa318-510) as well as SARS-CoV-2 (COVID-19) Spike protein.

Click for more product details

Diaclone now proposes a complete range of  Antibodies and Recombinant proteins for SARS-CoV-2 research and diagnostics :

Anti-SARS-CoV-2 Nucleoprotein CR3018 - details

Anti-SARS-CoV-2 Spike S1 Protein CR3022 (IgA) - details

Recombinant proteins SPIKE RBD, NUCLEOPROTEIN and ACE2 - visit the page dedicated to this new line of products

Other variants available soon!

Please contact your local distributor or email us directly at info@diaclone.com

Other news

  • ELISPOT
    Diaclone ELISpot assays, tried and trusted by researchers worldwide
    Publication date : 2021-04-01
    Our BEST SELLER the IFNγ ELISpot assay, is widely used in clinical cancer studies and also in COVID-19 research Read more
  • ELISPOT man
    ELISpot Kits - A new format to meet your demands
    Publication date : 2021-02-25
    The Diaclone ELISpot kit range is extended with a new 2 PLATE FORMAT Read more
  • Seed machine
    Monoclonal Antibody Platform
    Publication date : 2021-02-05
    Diaclone and Seed Biosciences collaborate on the development of a new workflow for a faster and more efficient antibody development process Read more
  • Variant
    New! SARS-CoV-2 SPIKE GLYCOPROTEIN RBD VARIANTS
    Publication date : 2021-01-20
    Diaclone is finalizing the development of 3 new SARS-CoV-2 protein variants: SARS-CoV-2 Spike RBD Variant N501Y, SARS-CoV-2 Spike RBD Variant 501Y.V2, SARS-CoV-2 Spike RBD Variant B.1.1.248 Developed in our laboratories in Besançon (France) Read more
  • Covid ELISA set
    New at Diaclone - SARS-CoV-2 ELISA set
    Publication date : 2020-11-24
    Build your own serological assay with our new SARS-CoV-2 ELISA set... Read more
  • Covid rec proteins
    NEW!... RECOMBINANT HUMAN SARS-CoV-2 PROTEINS
    Publication date : 2020-10-15
    Developed in our laboratories in Besançon (France) Read more
  • IL1RAP
    IL1RAP, a therapeutic target for oncologic treatment
    Publication date : 2020-08-03
    Discover our new IL1RAP clones... Read more
  • Exosomes
    What you need to know about Exosomes
    Publication date : 2020-07-01
    “Huge opportunities”. “Many hurdles”. “Enormous potential”.... Read more
  • cytokines
    Fast track your Covid-19 Research with Diaclone’s CYTOKINES
    Publication date : 2020-05-18
    Essential tools for Cytokine Storm monitoring & Immunotherapy development... Read more
  • Virus
    Essential tools for COVID-19 and Immunotherapy research
    Publication date : 2020-04-02
    Diaclone provides a large panel of research tools, Monoclonal Antibodies and Immunoassays, for measuring the levels of released cytokines triggered by viral infection (cytokine release syndrome - CRS), including a complete range of human IL-6 and TNF-α products. Read more
  • Diaclone est partenaire d’un projet européen d’envergure associant une douzaine de partenaires de la région de Besançon.
    MiMédi Project
    Publication date : 2019-08-29
    Diaclone is a partner in a major European project involving a dozen partners from the Besançon region. Read more

Product search